I.V. Сhikisheva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
I.V. Сhikisheva has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Lyudmila Viktorovna Kochetova
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky
1 shared publication - Nadezhdà M. Markelova
Krasnoyarsk State Medical University
1 shared publication - Regina Alexandrovna Pakhomova
Russian Biotechnological University (ROSBIOTECH University)
1 shared publication - Ruslan Yu Khlobystin
Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky, Russia
1 shared publication - Stanislav I. Petrushko
Krasnoyarsk State Medical University named after Professor V.F. Voino-Yasenetsky
1 shared publication - Vasiliy Yaroslavovich Kolesnik
Russian Biotechnological University (ROSBIOTECH University)
1 shared publication
Latest Publications
- 28 October 2025
- Published by Academy of International Scientific Cooperation in "Medical & Pharmaceutical Journal "Pulse"
- Vol. 27 (11)
DIAGNOSTIC AND THERAPEUTIC ASPECTS OF HEPATIC ENCEPHALOPATHY IN OBSTRUCTIVE JAUNDICE
Hepatic encephalopathy (HE) associated with mechanical (obstructive) jaundice is a complex multifactorial syndrome developing under the influence of hyperammonemia, biliary neurotoxicity, and endotoxemia. Under cholestasis, the toxic effects of ammonia and bile acids are enhanced, leading to astrocyte swelling, neuroinflammation, and cognitive impairment. The combination of metabolic, infectious, and hemodynamic factors contributes to disease severity and increased mortality in patients with biliary obstruction. This study summarizes current data on pathogenesis, clinical manifestations, diagnosis, and treatment of HE in obstructive jaundice. A review of international and Russian publications, clinical studies, and recommendations was conducted. The key pathogenetic mechanisms of HE includes hyperammonemia, biliary toxicity, and endotoxemia, which progress with prolonged cholestasis. Comprehensive diagnostics involving the West Haven scale, psychometric testing, EEG, and MRI is considered most informative. Therapeutic strategies should include the elimination of biliary obstruction (ERCP or surgery), ammonia-lowering agents (lactulose, rifaximin, L-ornithine-L-aspartate), supportive therapy (albumin, branched-chain amino acids, antioxidants), and correction of precipitating factors. Promising directions for further research include extracorporeal detoxification and modulation of intestinal microbiota.
- 28 October 2025
- Published by Academy of International Scientific Cooperation in "Medical & Pharmaceutical Journal "Pulse"
- Vol. 27 (11)
DIAGNOSTIC AND THERAPEUTIC ASPECTS OF HEPATIC ENCEPHALOPATHY IN OBSTRUCTIVE JAUNDICE
Hepatic encephalopathy (HE) associated with mechanical (obstructive) jaundice is a complex multifactorial syndrome developing under the influence of hyperammonemia, biliary neurotoxicity, and endotoxemia. Under cholestasis, the toxic effects of ammonia and bile acids are enhanced, leading to astrocyte swelling, neuroinflammation, and cognitive impairment. The combination of metabolic, infectious, and hemodynamic factors contributes to disease severity and increased mortality in patients with biliary obstruction. This study summarizes current data on pathogenesis, clinical manifestations, diagnosis, and treatment of HE in obstructive jaundice. A review of international and Russian publications, clinical studies, and recommendations was conducted. The key pathogenetic mechanisms of HE includes hyperammonemia, biliary toxicity, and endotoxemia, which progress with prolonged cholestasis. Comprehensive diagnostics involving the West Haven scale, psychometric testing, EEG, and MRI is considered most informative. Therapeutic strategies should include the elimination of biliary obstruction (ERCP or surgery), ammonia-lowering agents (lactulose, rifaximin, L-ornithine-L-aspartate), supportive therapy (albumin, branched-chain amino acids, antioxidants), and correction of precipitating factors. Promising directions for further research include extracorporeal detoxification and modulation of intestinal microbiota.